BTSG vs CVS
BTSG: BrightSpring Health Services provides integrated pharmacy and clinical care solutions specifically tailored for complex, high-needs patient populations in home and community settings. CVS: A leading health solutions company integrating retail pharmacy, pharmacy benefit management, and insurance services to manage health costs and improve access to care.
Side-by-side fundamentals
| Metric | BTSG | CVS | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $62.42 | $94.75 | |
| Market cap | $12.4B | $121.2B | |
| P/E as of 2026-10-20 | 37.83 | 25.00 | CVS lower |
| Net margin FY2025, SEC XBRL | +1.5% | +0.4% | BTSG higher |
| Gross margin FY2025, SEC XBRL | +11.8% | n/a | |
| Operating margin FY2025, SEC XBRL | +2.3% | +1.2% | BTSG higher |
| ROE FY2025, SEC XBRL | +10.2% | +2.4% | BTSG higher |
| ROA FY2025, SEC XBRL | +3.0% | +0.7% | BTSG higher |
| Debt / equity | 1.07 | 0.77 | CVS lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +28.2% | +7.8% | BTSG higher |
| Revenue CAGR (3y) SEC XBRL | +18.7% | +7.6% | BTSG higher |
| Dividend yield as of 2026-09-03 | n/a | +3.0% | |
| Dividend streak (yrs) SEC XBRL | 0 | 19 | CVS higher |
| Beta as of 2026-09-03 | 1.18 | 0.28 | |
| 1-year return as of 2026-10-20 close | +104.9% | +14.9% | BTSG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.